HoracioKaufmannMD

Hospital/Neurohospitalist

Felicia B. Axelrod Professor of Dysautonomia Research, Department of Neurology Professor, Department of Medicine Professor, Department of Pediatrics Director, Autonomic Disorders Fellowship Program Director, Dysautonomia Center Director, Division of Autonomic Disorders NYU School of Medicine

Join to view full profile

Dr. Kaufmann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kaufmann's full profile

Already have an account?

Office
5 E 98th St
New York, NY 10029
Phone+1 212-241-7076

Fax+1 212-860-4952

Education & Training

Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Neurology, 1983 - 1986
University of Buenos AiresClass of 1978

Certifications & Licensure

NY State Medical License 1986 - 2025
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension Start of enrollment: 2001 Apr 01
Completed
Phase 2
Droxidopa in Treating Patients With Neurogenic Hypotension Start of enrollment: 1999 Mar 01
Completed
Not Applicable
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) Start of enrollment: 2008 Jan 01
Completed
Phase 3
Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) Start of enrollment: 2008 Jan 01
Completed
Phase 3
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304) Start of enrollment: 2009 Jan 01
Completed
Phase 3
Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia Start of enrollment: 2009 Dec 01
Completed
Phase 3
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension Start of enrollment: 2011 Mar 01
Completed
Safety Study of Pyridostigmine in Heart Failure Start of enrollment: 2011 Oct 01
Completed
Phase 2
Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy Start of enrollment: 2012 Feb 01
Completed
Phase 2, Phase 3
Natural History Study of Synucleinopathies Start of enrollment: 2011 Jun 01
Recruiting
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy Start of enrollment: 2013 Nov 01
Terminated
Phase 3
The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia Start of enrollment: 2013 Mar 01
Completed
Phase 3
Carbidopa for the Treatment of Excessive Blood Pressure Variability Start of enrollment: 2015 Sep 01
Completed
Phase 2
Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease Start of enrollment: 2016 Feb 01
Completed
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) Start of enrollment: 2017 Sep 09
Completed
Phase 2
Norepinephrine Transporter Blockade, Autonomic Failure (NETAF) Start of enrollment: 2016 Aug 29
Completed
Phase 2
A Trial of Cognitive Behavioral Therapy in Familial Dysautonomia Start of enrollment: 2016 Dec 06
Completed
Not Applicable
Telemedicine Clinical Trial for Cognitive Behavioral Therapy in Familial Dysautonomia Start of enrollment: 2019 Apr 01
Withdrawn
Not Applicable
Join now to see all

Publications & Presentations

PubMed

149 citations
The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale
Horacio Kaufmann, Richard Malamut, Lucy Norcliffe-Kaufmann, Kathleen Rosa, Roy Freeman
Clinical Autonomic Research. 2012-04-01
28 citations
Hyperdopaminergic crises in familial dysautonomia A randomized trial of carbidopa
Lucy Norcliffe-Kaufmann, Jose Martinez, Felicia B. Axelrod, Horacio Kaufmann
Neurology. 2013-04-23
6 citations
Fear conditioning as a pathogenic mechanism in the postural tachycardia syndrome.
Lucy Norcliffe-Kaufmann, Jose-Alberto Palma, Jose Martinez, Celeste Camargo, Horacio Kaufmann
Brain. 2022-11-21

Other

Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension
Kaufmann H, Kaplan NM, Freeman R
http://www.uptodate.com/contents/mechanisms-causes-and-evaluation-of-orthostatic-and-postprandial-hy
UpToDate, Wolters Kluwer Health - 2012-08-01
Treatment of orthostatic and postprandial hypotension
Kaufmann H, Kaplan NM, Freeman R
http://www.uptodate.com/contents/treatment-of-orthostatic-and-postprandial-hypotension
UpToDate, Wolters Kluwer Health - 2010-09-22
Postural tachycardia syndrome
Kaufmann H, Freeman R
http://www.uptodate.com/contents/postural-tachycardia-syndrome
UpToDate, Wolters Kluwer Health - 2013-02-25

Press Mentions

Clinical and Imaging Biomarkers in Parkinsonian Syndromes, Upcoming Webinar Hosted by XtalksApril 26th, 2021
The Privilege and Responsibility of Caring for Patients with Rare Genetic DisordersFebruary 12th, 2021
Do Jewish Genetic Diseases Increase the Risk of COVID-19?May 12th, 2020
Join now to see all